Insight Molecular Diagnostics Stock Alpha and Beta Analysis
| IMDX Stock | 5.82 0.41 7.58% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Insight Molecular Diagnostics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Insight Molecular over a specified time horizon. Remember, high Insight Molecular's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Insight Molecular's market risk premium analysis include:
Beta 2.74 | Alpha 0.74 | Risk 5.5 | Sharpe Ratio 0.19 | Expected Return 1.05 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Insight Molecular Backtesting, Insight Molecular Valuation, Insight Molecular Correlation, Insight Molecular Hype Analysis, Insight Molecular Volatility, Insight Molecular History and analyze Insight Molecular Performance. Insight Molecular Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Insight Molecular market risk premium is the additional return an investor will receive from holding Insight Molecular long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Insight Molecular. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Insight Molecular's performance over market.| α | 0.74 | β | 2.74 |
Insight Molecular expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Insight Molecular's Buy-and-hold return. Our buy-and-hold chart shows how Insight Molecular performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Insight Molecular Market Price Analysis
Market price analysis indicators help investors to evaluate how Insight Molecular stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Insight Molecular shares will generate the highest return on investment. By understating and applying Insight Molecular stock market price indicators, traders can identify Insight Molecular position entry and exit signals to maximize returns.
Insight Molecular Return and Market Media
The median price of Insight Molecular for the period between Thu, Sep 25, 2025 and Wed, Dec 24, 2025 is 5.52 with a coefficient of variation of 24.71. The daily time series for the period is distributed with a sample standard deviation of 1.31, arithmetic mean of 5.31, and mean deviation of 1.07. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | iMDx Reports Kidney Transplant Patient Achieved Immune Reset with Novel Therapy and GraftAssure Monitoring | 10/06/2025 |
2 | Acquisition by Arno Andrew of 141084 shares of Insight Molecular at 0.3544 subject to Rule 16b-3 | 10/28/2025 |
3 | Acquisition by Andrea James of 50000 shares of Insight Molecular subject to Rule 16b-3 | 10/31/2025 |
4 | Biodesix Gets a Buy from Lake Street - The Globe and Mail | 11/05/2025 |
5 | Insight Molecular Diagnostics Inc Q3 2025 Earnings Call Highlights Pioneering Advances ... | 11/12/2025 |
6 | Disposition of 12175 shares by Andrea James of Insight Molecular at 6.01 subject to Rule 16b-3 | 11/13/2025 |
7 | Will Insight Molecular Diagnostics Inc. stock remain on Wall Street radar - Analyst Upgrade Safe Investment Capital Preservation Plans - newser.com | 11/17/2025 |
8 | Acquisition by Riggs Josh of 800000 shares of Insight Molecular at 0.2132 subject to Rule 16b-3 | 11/20/2025 |
9 | Were Keeping An Eye On Insight Molecular Diagnostics Cash Burn Rate | 12/01/2025 |
10 | Hedge funds investors control 50 percent of Insight Molecular Diagnostics Inc. and were rewarded last week after stock increased 11 | 12/23/2025 |
About Insight Molecular Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Insight or other stocks. Alpha measures the amount that position in Insight Molecular has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Dividend Yield | 0.001654 | 0.00147 | Price To Sales Ratio | 16.54 | 15.71 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Insight Molecular in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Insight Molecular's short interest history, or implied volatility extrapolated from Insight Molecular options trading.
Build Portfolio with Insight Molecular
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.